DT
OVID icon

Diversified Trust’s Ovid Therapeutics OVID Stock Holding History

Diversified Trust’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,964
Closed -$106K – 860
2021
Q4 		$106K Hold
32,964
– – ﹤0.01% 805
2021
Q3 		$111K Sell
32,964
-2,099
-6% -$7.65K ﹤0.01% 763
2021
Q2 		$137K Buy
+35,063
New +$138K ﹤0.01% 744

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Diversified Trust's OVID Position: Q1 2022 in Review

Diversified Trust sold out of Ovid Therapeutics (OVID) in Q1 2022, closing a stake of 32,964 shares — an estimated $106K sold.

Diversified Trust first reported a position in OVID in Q2 2021 and held it in 3 quarters. The position peaked at $137K in Q2 2021. 62 funds tracked by Wall St. Rank hold OVID as of Q1 2022.

  • Diversified Trust reported no remaining Ovid Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Diversified Trust sold 32,964 Ovid Therapeutics shares in Q1 2022, an estimated $106K.
  • Diversified Trust first reported a position in Ovid Therapeutics in Q2 2021 and held it in 3 quarters.
  • Diversified Trust's Ovid Therapeutics position peaked at $137K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2022.

Based on Diversified Trust's 13F filing for Q1 2022, filed 7 Apr 2022.